The current approval of Takeda’s Takhzyro pre-filled pen is an addition to the existing 150 mg and 300 mg pre-filled syringes ...

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor ...

Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...

I want to express my heartfelt gratitude for the outpouring of support and well wishes following last Thursday's announcement of my future role as Takeda’s CEO, starting June 2026. Reading your ...

Takeda (TAK) announced that the EMA has approved an additional two mL pre-filled pen option for Takhzyro for subcutaneous administration in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Last February, Kim Kardashian shared a photo of Ivan Cantu on social media, saying he was a death row inmate and that state of Texas would execute him in two days. Neither were true. The Cantu ...

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

Kim Kardashian is a globally recognized media personality, entrepreneur, and reality TV star. She first rose to fame with Keeping Up with the Kardashians, which featured her mother Kris and ...